Dermatology Times

DECEMBER 23, 2024

Hidradenitis suppurativa requires clinical vigilance, empathy, and the courage to escalate therapy early.

Therapy 64

Therapy Clinic 64

Alison Bladh

DECEMBER 23, 2024

Discover How to Navigate Midlife Health with Confidence Are you feeling overwhelmed by the changes of perimenopause and menopause? Youre not alone but it doesnt have to be this way! I joined Rachael Vassar on her Experience Health podcast to discuss how women can not only survive but thrive during this transformative phase of life. As a Registered Nutritional Therapist and Esthetician with decades of experience, I shared advanced strategies to support your hormonal health, manage common symptoms

Management 59

Management Tools Esthetician 59

US Dermatologt Partners

DECEMBER 23, 2024

Melanoma is a serious form of skin cancer, and early detection is crucial since treatment is more likely to be successful for early-stage melanoma. According to Dr. Arianna Yanes , MD, FAAD of U.S. Dermatology Partners in Annapolis , The common signs of melanoma are referred to as the A, B, C, D, Es. This stands for Asymmetry, Border irregularity, Color variation, large Diameter, and Evolving over time.

Dermatology 36

Dermatology Consultation Consultations Office 36

Lydia Sarfati

DECEMBER 23, 2024

90-minute interactive virtual business class with Repchage Founder and CEO Lydia Sarfati. Live Presentation – January 20th, 2025 – 12 pm to 1:30pm Already A Member? SIGN IN VIRTUAL MASTER CLASS: Dermaplaning with Red-Out Facial 90-minute interactive virtual business class with Repchage Founder and CEO Lydia Sarfati. Live Presentation – January 20th, 2025 – 12 pm to 1:30pm SIGN UP $20.00 Monthly Access Month long access to live Academy courses as well access to library of

Dermaplaning 52

Dermaplaning Facials Education 52

Texas Dermatology

DECEMBER 23, 2024

If you are ready to start laser hair removal, you may be curious about the preparation process. Proper preparation minimizes the risk of irritation, enhances the lasers ability to target hair follicles, and helps achieve optimal results in fewer sessions. Additionally, understanding what to avoidlike sun exposure or certain skincare productscan prevent unwanted complications and ensure their skin is in the best condition for treatment.

Hair Removal 36

Hair Removal Med Spa Waxing Chemical Peels 36

The Dermatology Digest

DECEMBER 23, 2024

Biofrontera Inc. has installed the 100 th commercial RhodoLEDXL Lamp in the U.S. market. The RhodoLED XL was approved by the U.S. Food and Drug Administration (FDA) for use in combination with aminolevulinic acid HCl (Ameluz) in 2022 and was launched in June 2024. Ameluz is used in combination with photodynamic therapy using BF-RhodoLED or RhodoLED XL lamp for the lesion-directed and field-directed treatment of actinic keratoses of mild to moderate severity on the face and scalp.

Marketing 36

Marketing Office Therapy Dermatology 36

Dermatology Times

DECEMBER 23, 2024

At the inaugural Horizons in Advanced Practice meeting, Noor highlighted the value of amplifying the voices of physician assistants and nurse practitioners to advance patient care.

36

36

Dermatology Times

DECEMBER 23, 2024

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in prurigo nodularis this year.

Dermatology 36

Dermatology Therapy 36

Dermatology Times

DECEMBER 23, 2024

These promising results align with what was discovered in the single-ascending dose portion of the trial earlier this year.

36

36

Dermatology Times

DECEMBER 23, 2024

Dermatology Times is looking back on the top stories in dermatology that involve strides in skin health equity: addressing disparities for skin of color, women, LGBTQ+ patients, and improving care access.

Skin Health 36

Skin Health Dermatology 36

Dermatology Times

DECEMBER 23, 2024

Panelists discuss how the safety data from the Effisayil 2 trial show that spesolimab was generally well-tolerated, with most adverse events being mild-to-moderate, primarily consisting of injection site reactions, and no new safety concerns emerging during the study.

Safety 36

Safety Injections 36

Dermatology Times

DECEMBER 23, 2024

Panelists discuss how emerging nonsurgical options such as hedgehog pathway inhibitors, immune checkpoint inhibitors, and photodynamic therapy are expanding treatment possibilities for patients with advanced basal cell carcinoma (BCC), particularly for those unsuitable for or unresponsive to traditional surgical interventions.

Management 36

Management Treatments Therapy 36

Dermatology Times

DECEMBER 23, 2024

Panelists discuss how the Effisayil 2 trial's results suggest that spesolimab offers a promising strategy for reducing the frequency and severity of GPP flares, potentially revolutionizing the management of this severe and life-threatening condition.

Management 36

Management 36

Dermatology Times

DECEMBER 23, 2024

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in rosacea this year.

Rosacea 36

Rosacea Dermatology Therapy 36